Joe Arrington Cancer Center is a clinical research site located in Lubbock, Texas, United States 79410.
Crixeo Health Trust Score: 77/100 (FAIR). This profile has not yet been claimed by the site owner.
Joe Arrington Cancer Center has participated in 13 clinical trials with 2 currently active.
Therapeutic areas: Acute Myeloid Leukemia, B-Cell Chronic Lymphocytic Leukemia (B-CLL), Non-Small-Cell Lung Carcinoma.
Sponsors: Jazz Pharmaceuticals, Genzyme, a Sanofi Company, Case Comprehensive Cancer Center.
Trust Score: 77/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
Joe Arrington Cancer Center has a Crixeo Trust Score of 77/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Joe Arrington Cancer Center has 13 clinical trials on record, with 2 currently active. Their work covers Acute Myeloid Leukemia, B-Cell Chronic Lymphocytic Leukemia (B-CLL), Non-Small-Cell Lung Carcinoma.
Yes — Joe Arrington Cancer Center holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.